市场调查报告书
商品编码
1471051
永续药品包装市场:按材料、包装类型、产品类型和最终用户划分 - 2024-2030 年全球预测Sustainable Pharmaceutical Packaging Market by Material (Glass, Metal, Paper & Paperboard), Packaging Type (Biodegradable, Recyclable, Reusable), Product Type, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年永续药品包装市场规模为763.9亿美元,预计2024年将达857亿美元,2030年将达到1,793.3亿美元,复合年增长率为12.96%。
永续生产是药品包装行业的一个不断增长的趋势,使用环保材料、製程和技术来减少废弃物和能源消耗,同时提供卓越的性能。我们为世界各地的製药和医疗保健公司提供全面的永续性包装计划,减少包装设计中的塑胶使用,并减少整个包装供应链的碳足迹。消费者对环保包装的偏好不断增加、药品产量增加以及政府对永续包装的措施正在推动市场开拓。然而,安装和操作机械的高资本要求以及环保材料交叉污染的风险可能会阻碍永续包装在製药业的采用率。儘管如此,主要参与者之间不断出现的合併活动和新原材料的引入可能会为未来几年的市场开拓创造利润丰厚的机会。
主要市场统计 | |
---|---|
基准年[2023] | 763.9亿美元 |
预测年份 [2024] | 857亿美元 |
预测年份 [2030] | 1793.3亿美元 |
复合年增长率(%) | 12.96% |
持续创新专注于开发生物分解性聚合物材料和回收计划
玻璃包装以其优异的阻隔性、耐用性和惰性而闻名,仍然是许多製药应用的首选。它特别适用于产品完整性至关重要的脆弱产品,例如疫苗和注射。金属包装主要包括铝和钢,由于其优异的阻隔性、重量轻和可回收性,在製药业受到高度重视。铝用于泡壳、管材和气雾罐中,以保护它们免受潮湿和光照。纸和纸板包装涵盖从盒子、标籤到插页等多种产品,并为回收和堆肥提供了绝佳的机会。纸张和纸板广泛用于二次包装,因其可印刷性以支持品牌推广和讯息传播而受到高度重视。塑胶包装因其多功能性、成本效益和优异的阻隔性而广普及。然而,对永续性的担忧正在推动该行业转向创新技术,例如生物分解性聚合物和回收计划。生质塑胶是一种现代包装方法,源自于植物油、稻草和木片等可再生生物质资源。高密度聚苯乙烯(HDPE) 是一种刚性、高强度塑料,以其拉伸强度、耐化学性和防潮性而闻名。在医药领域,广泛用于锭剂、维生素、糖浆等容器。
低密度聚乙烯(LDPE)是一种软包装材料,具有优异的韧性、透明性和耐化学性。这种塑胶通常用于製造药品包装中使用的袋子、管子和薄膜。聚对苯二甲酸乙二酯是一种耐用、轻质的塑料,因其优异的气体和湿气阻隔性而在药品包装行业中得到广泛认可,有效保护产品的完整性。聚丙烯具有高熔点,非常适合可热灌装和灭菌的产品。它对化学溶剂、酸和碱的耐受性使其成为药品容器的通用材料,包括那些设计用于高压釜灭菌的容器。聚苯乙烯是一种轻质、易于成型的塑料,通常用于包装需要高度保护的药品,例如疫苗托盘和药物分配器。聚氯乙烯具有柔韧性、耐用性和透明性,适合製药业的泡壳包装。 聚氯乙烯具有强大的石油和天然气阻隔性,可维持药品的完整性和有效性。
最终用户:製药公司更喜欢创新包装来延长保质期并保持产品的完整性。
合约包装公司以合约形式向製药公司提供包装服务。这些公司更有可能青睐软包装解决方案,在不损害药物完整性的情况下减少材料使用。合约包装的永续性也着重于使用可回收材料和简化包装流程以最大限度地减少废弃物。医院、疗养院和长期照护机构等机构药局优先考虑确保病人安全、剂量准确性和药物完整性的包装。永续性倡议的重点是减少包装尺寸和材料,同时保持医疗保健环境中所需的严格法规遵循。
药品製造商是促进永续包装的核心,因为他们可以直接控制包装材料和包装技术的选择。重点是能够延长保质期、维持产品完整性并减少碳排放的创新包装。这包括采用生物分解性材料、减少包装层数、提高包装效率。零售药局是向消费者提供药品的最终分发点。零售药品包装的永续性着重于消费者便利性、可回收性以及正确处置和回收的教育。人们越来越多地采用消费者可以在家中轻鬆回收的极简设计和材料。
区域洞察
由于先进的回收设施、环保材料的快速采用以及积极的政府倡议,欧洲、中东和非洲地区的永续药品包装市场正在高度发展和开拓。此外,欧洲绿色交易保证可重复使用的包装选择,消除不必要的包装,限制过度包装,提供支持正确回收的清晰标籤,并扩大马苏的市场范围。由于亚太地区製药业的显着增长和对环境保护的快速关注,该地区也占据了重要的市场占有率。此外,中国、印度、泰国、新加坡和马来西亚等亚洲国家的政府正在积极推出新的法规和指导方针,鼓励采用永续和环保的包装解决方案,从而扩大市场范围。同时,在美洲,永续包装解决方案(例如使用玉米淀粉、甘蔗和木薯用于药品的植物来源包装)正在开发中,市场开拓也在取得进展。
FPNV定位矩阵
FPNV定位矩阵对于评估永续药品包装市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对永续药品包装市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争评估及资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行综合评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.永续药品包装市场的市场规模与预测为何?
2.在永续药品包装市场的预测期间内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.永续药品包装市场的技术趋势和法规结构是什么?
4.永续药品包装市场主要供应商的市场占有率为何?
5. 进入永续医药包装市场的合适型态和策略手段是什么?
[184 Pages Report] The Sustainable Pharmaceutical Packaging Market size was estimated at USD 76.39 billion in 2023 and expected to reach USD 85.70 billion in 2024, at a CAGR 12.96% to reach USD 179.33 billion by 2030.
Sustainable production is a growing trend within the pharmaceutical packaging industry to use environmentally friendly materials, processes, and technologies to reduce waste and energy consumption while providing superior performance. Delivering comprehensive sustainability packaging programs for pharmaceutical and healthcare companies across the globe to reduce plastic in packaging design and reduce carbon footprint across the packaging supply chain. The rising consumer preference for eco-friendly packaging, growing pharmaceutical product production, and government initiatives for sustainable packaging are driving market development. However, the requirement of high capital for machine installation and operation and the risk of cross-contamination through eco-friendly materials may hamper the adoption rate of sustainable packaging in the pharmaceutical sector. Nevertheless, the emerging amalgamation activities among major players and the introduction of novel raw materials may create lucrative opportunities for market development in the coming years.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 76.39 billion |
Estimated Year [2024] | USD 85.70 billion |
Forecast Year [2030] | USD 179.33 billion |
CAGR (%) | 12.96% |
Material: Ongoing innovations focusing on development of biodegradable polymers and recycling programs
Glass packaging, renowned for its excellent barrier properties, durability, and inertness, remains a preferred choice for many pharmaceutical applications. It is particularly favored for sensitive products, including vaccines and injectables, where product integrity is paramount. Metal packaging, encompassing aluminum and steel primarily, is valued in the pharmaceutical sector for its exceptional barrier qualities, lightweight, and recyclability. Aluminum, used for blisters, tubes, and aerosol cans, protects against moisture and light. Paper & paperboard packaging includes a wide range of products, from boxes and labels to inserts, offering significant opportunities for recycling and compostability. Paper and paperboard are extensively used for secondary packaging and are appreciated for their printability, which supports branding and information dissemination. Plastic packaging is pervasive owing to its versatility, cost-effectiveness, and excellent barrier properties. However, sustainability concerns push the industry towards innovations such as biodegradable polymers and recycling programs. Bioplastics represent a modern approach to packaging obtained from renewable biomass sources, including vegetable fats, oils, straws, and woodchips. High-Density Polyethylene (HDPE) is a rigid, high-strength plastic known for its increased tensile strength, chemical resistance, and moisture barriers. It is widely used in the pharmaceutical sector for containers for products such as pills, vitamins, and syrups.
Low-Density Polyethylene (LDPE) provides a flexible packaging option recognized for its toughness, transparency, and chemical resistance. This plastic type is commonly used for producing bags, tubing, and films used in pharmaceutical packaging. Polyethylene terephthalate is a strong, lightweight plastic widely recognized in the pharmaceutical packaging industry for its superior barrier properties against gas and moisture, effectively protecting the product's integrity. Polypropylene is noted for its high melting point, making it ideal for hot-filled, sterilizable products. Its resistance to chemical solvents, acids, and bases makes it a versatile material for pharmaceutical containers, including those designed for autoclave sterilization. Polystyrene is a lightweight, easily moldable plastic often used in pharmaceutical packaging for items requiring a high degree of protection, such as vaccine trays and medication dispensers. Polyvinyl chloride is a flexible, durable plastic with excellent transparency, making it suitable for blister packaging in the pharmaceutical industry. It offers a strong barrier against oil and gas, preserving medication integrity and efficacy.
End-User: Pharmaceutical companies prefer innovative packaging to extend product shelf life and maintain integrity
Contract packaging organizations provide packaging services to pharmaceutical companies on a contract basis. These entities have shown a marked preference for flexible packaging solutions that reduce material usage without compromising the integrity of the pharmaceutical products. Sustainability in contract packaging also focuses on using recyclable materials and improving the efficiency of packaging processes to minimize waste. Institutional pharmacies, including those within hospitals, nursing homes, and long-term care facilities, prioritize packaging that ensures patient safety, dosage accuracy, and medication integrity. Sustainability initiatives focus on reducing packaging sizes and materials while maintaining the strict regulatory compliance required in healthcare settings.
Pharmaceutical manufacturers are at the core of the push for sustainable packaging, as they directly control the choice of packaging materials and technologies. The focus is on innovative packaging that can extend shelf life, maintain product integrity, and reduce carbon footprint. This includes the adoption of biodegradable materials, reduction in packaging layers, and improvements in packaging efficiency. Retail Pharmacies serve as the final distribution point for pharmaceutical products to consumers. Sustainability in retail pharmacy packaging focuses on consumer convenience, recyclability, and education on proper disposal and recycling. The adoption of minimalistic designs and materials that consumers can easily recycle at home is on the rise.
Regional Insights
The EMEA region's sustainable pharmaceutical packaging market is highly evolving and developing owing to advanced recycling facilities, rapid adoption of eco-friendly materials, and favorable government initiatives. Moreover, the European Green Deal ensures reusable packaging options, eliminates unnecessary packaging, limits overpackaging, and provides clear labels to support correct recycling, expanding the market scope. The Asia-Pacific region also covers a significant market share due to the substantial growth of the pharmaceutical industry in the province and the rapid inclination towards environmental protection. Further, governments of Asian countries, such as China, India, Thailand, Singapore, and Malaysia, are eagerly deploying novel regulations and guidelines to encourage people to adopt sustainable and eco-friendly packaging solutions, expanding the market scope. On the other hand, the Market is also widely explored in the American region as players are developing novel sustainable packaging solutions, such as plant-based packaging that uses corn starch, sugarcane, and cassava for pharmaceutical products.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Sustainable Pharmaceutical Packaging Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Sustainable Pharmaceutical Packaging Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Sustainable Pharmaceutical Packaging Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Amcor Group GmbH, Berry Global, Inc., Bormioli Pharma S.p.A., CCL Industries, Inc., Coleman Container limited, Comar, LLC, Constantia Flexibles International GmbH, Corning Incorporated, DaklaPack Group, Drug Plastics Group, Gerresheimer AG, International Paper, Intertek Group plc, IPACKCHEM Group, KP Holding GmbH & Co. KG, Korber Pharma GmbH, Oliver Healthcare Packaging, Origin Pharma Packaging, PAPACKS Sales GmbH, Schott AG, SGD S.A., SIGMA Medical Supplies Corporation, Strobel GmbH, Syntegon Technology GmbH, The Dow Chemical Company, Tri-pack Packaging Systems Ltd., Tubettificio Perfektup S.r.l., Vetter Pharma-Fertigung GmbH & Co. KG, and West Pharmaceutical Services, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Sustainable Pharmaceutical Packaging Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Sustainable Pharmaceutical Packaging Market?
3. What are the technology trends and regulatory frameworks in the Sustainable Pharmaceutical Packaging Market?
4. What is the market share of the leading vendors in the Sustainable Pharmaceutical Packaging Market?
5. Which modes and strategic moves are suitable for entering the Sustainable Pharmaceutical Packaging Market?